scholarly journals Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control

2013 ◽  
Vol 68 (12) ◽  
pp. 2927-2933 ◽  
Author(s):  
C. A. Marwick ◽  
N. Yu ◽  
M. C. Lockhart ◽  
C. C. McGuigan ◽  
C. Wiuff ◽  
...  
2014 ◽  
Vol 20 (12) ◽  
pp. O1067-O1074 ◽  
Author(s):  
M.P.M. Hensgens ◽  
O.M. Dekkers ◽  
A. Demeulemeester ◽  
A.G.M. Buiting ◽  
P. Bloembergen ◽  
...  

2015 ◽  
Vol 167 (2) ◽  
pp. 384-389 ◽  
Author(s):  
Larry K. Kociolek ◽  
Hannah L. Palac ◽  
Sameer J. Patel ◽  
Stanford T. Shulman ◽  
Dale N. Gerding

2011 ◽  
Vol 11 (1) ◽  
Author(s):  
Jennifer L Kuntz ◽  
Elizabeth A Chrischilles ◽  
Jane F Pendergast ◽  
Loreen A Herwaldt ◽  
Philip M Polgreen

2017 ◽  
Vol 51 (10) ◽  
pp. 848-854 ◽  
Author(s):  
Paul O. Lewis ◽  
Timothy S. Lundberg ◽  
Jennifer L. Tharp ◽  
Clay W. Runnels

Background: Proton pump inhibitors (PPIs) have been identified as a significant risk factor for the development of Clostridium difficile infection (CDI). Probiotics given concurrently with antibiotics have been shown to have a moderate impact on preventing CDI. Objective: To evaluate the effectiveness of hospital-wide interventions designed to reduce PPI use and increase probiotics and whether these interventions were associated with a change in the incidence of hospital onset (HO)-CDI. Methods: This retrospective cohort study compared 2 fiscal years: July 2013 to June 2014 (FY14) and July 2014 to June 2015 (FY15). In July of FY15, global educational initiatives were launched targeting PPIs. Additionally, a HO-CDI prevention bundle was added to antibiotic-containing order sets targeting probiotics. Overall PPI use, probiotic use, and incidence of HO-CDI were recorded and compared for each cohort. Charts were also reviewed for patients who developed HO-CDI for the presence and appropriateness of a PPI and presence of probiotics. Results: The interventions resulted in a decrease in PPI use by 14% or 96 doses/1000 patient days (TPD; P = 0.0002) and a reduction in IV PPI use by 31% or 71 doses/TPD ( P = 0.0008). Probiotic use increased by 130% or 126 doses/TPD ( P = 0.0006). The incidence of HO-CDI decreased by 20% or 0.1 cases/TPD ( P = 0.04). Conclusions: A collaborative, multifaceted educational initiative directed at highlighting the risks associated with PPI use was effective in reducing PPI prescribing. The implementation of a probiotic bundle added to antibiotic order sets was effective in increasing probiotic use. These interventions were associated with a decrease in incidence of HO-CDI.


2019 ◽  
Author(s):  
Katie Saund ◽  
Krishna Rao ◽  
Vincent B. Young ◽  
Evan S. Snitkin

ABSTRACTIn a case-control study of patients with C. difficile infection we found no statistically significant association between the presence of trehalose utilization variants in infecting C. difficile strains and development of severe infection. These results do not support trehalose utilization conferring enhanced virulence in the context of human C. difficile infections.


Sign in / Sign up

Export Citation Format

Share Document